Ligand Pharmaceuticals reported $19.15M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US $ 41M 6.46M
Amgen AMGN:US $ 1256M 147M
Anika Therapeutics ANIK:US $ 8.16M 0.72M
Arrowhead Research ARWR:US $ 5.89M 4.71M
Baxter International BAX:US 1.28B 59M
Bristol Myers Squibb BMY:US $ 2882M 62M
Clovis Oncology CLVS:US $ 24.23M 1.9M
Eli Lilly And LLY:US $ 1659.3M 226M
Enanta Pharmaceuticals ENTA:US $ 1.25M 4.74M
Endo International Ordinary Shares ENDP:US $ 90.64M 10.36M
Harsco HSC:US $ 213.04M 23.14M
Heron Therapeutics HRTX:US $ 13.8M 5.58M
Insmed INSM:US $ 31.14M 17.43M
Intrexon XON:US $ 2.67M 1.75M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Lannett LCI:US $ 28.57M 2.58M
Ligand Pharmaceuticals LGND:US $ 19.15M 12.18M
Macrogenics MGNX:US $ 2.61M 1.12M
Pacira Pharmaceuticals PCRX:US $ 13.98M 0.86M
Rigel Pharmaceuticals RIGL:US $ 2.15M 2.46M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M
Veracyte VCYT:US $ 10.33M 0.94M